688506 Stock Overview
Engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sichuan Biokin Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥177.92 |
| 52 Week High | CN¥215.71 |
| 52 Week Low | CN¥76.32 |
| Beta | 0 |
| 11 Month Change | 7.86% |
| 3 Month Change | -2.24% |
| 1 Year Change | 103.64% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 455.13% |
Recent News & Updates
Sichuan Biokin PharmaceuticalLtd (SHSE:688506) Could Easily Take On More Debt
Aug 17
Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Earnings May Just Be The Starting Point
May 03Shareholder Returns
| 688506 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.8% | -2.4% | -1.6% |
| 1Y | 103.6% | -9.3% | -18.6% |
Return vs Industry: 688506 exceeded the CN Pharmaceuticals industry which returned -9.3% over the past year.
Return vs Market: 688506 exceeded the CN Market which returned -18.6% over the past year.
Price Volatility
| 688506 volatility | |
|---|---|
| 688506 Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 688506 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688506's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,086 | Yi Zhu | www.baili-pharm.com |
Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd. Fundamentals Summary
| 688506 fundamental statistics | |
|---|---|
| Market cap | CN¥71.35b |
| Earnings (TTM) | CN¥4.39b |
| Revenue (TTM) | CN¥5.90b |
16.2x
P/E Ratio12.1x
P/S RatioIs 688506 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688506 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.90b |
| Cost of Revenue | CN¥254.33m |
| Gross Profit | CN¥5.65b |
| Other Expenses | CN¥1.25b |
| Earnings | CN¥4.39b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 24, 2024
| Earnings per share (EPS) | 10.95 |
| Gross Margin | 95.69% |
| Net Profit Margin | 74.42% |
| Debt/Equity Ratio | 14.5% |
How did 688506 perform over the long term?
See historical performance and comparison